Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development.
OBJECTIVE
To investigate whether the systemic antibody response to Helicobacter pylori heat shock protein B can be considered, in addition to anti cytotoxin-associated protein [CagA) antibody determination, a further serological marker of increased risk of gastric cancer development.


METHODS
A total of 98 Giemsa positive Helicobacter pylori patients (28 with gastric cancer, 30 with duodenal ulcer and 40 with nonulcer dyspepsia) were studied. Serum samples obtained from all patients were tested for IgG antibodies to CagA (116 kDa), VacA [89kDa) and heat skock protein B (54 kDa) antigens of Helicobacter pylori by the Western blot technique.


RESULTS
26/28 patients [(92.9% with gastric carcinoma, 29/30 patients [96.7%) with duodenal ulcer and 30/40 patients (75.0%) with non-ulcer dyspepsia were seropositive for CagA protein. The prevalence of serum IgG antibody to CagA in the cancer patients was not significantly higher than in duodenal ulcer and non-ulcer dyspepsia patients. The prevalence of antibodies to VacA was not significantly different between gastric carcinoma and non-ulcer dyspepsia patients. In contrast the prevalence of systemic antibodies to heat skock protein B was significantly higher in gastric cancer patients (78.6%) than in duodenal ulcer (36.7%, p=0.002) or nonulcer dyspepsia patients (52.5%, p=0.029).


CONCLUSIONS
The detection of antibodies to heat shock protein B is proposed as an additional test which, in association with the determination of serum antibodies to CagA, could help in determining the risk of developing severe gastroduodenal disease, and gastric cancer, in particular.
Iaquinto
G
G
Division of Gastroenterology, G. Moscati Hospital, Avellino, Italy. iaquinto@tin.it
Todisco
A
A
Giardullo
N
N
D'Onofrio
V
V
Pasquale
L
L
De Luca
A
A
Andriulli
A
A
Perri
F
F
Rega
C
C
De Chiara
G
G
Landi
M
M
Taccone
W
W
Leandro
G
G
Figura
N
N
D000907:Antibodies, Bacterial / Q000097:blood*; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D015153:Blotting, Western; D004381:Duodenal Ulcer / Q000276:immunology; D004415:Dyspepsia / Q000276:immunology; D005260:Female; D006360:Heat-Shock Proteins / Q000276:immunology; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000276:immunology
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D015415:Biomarkers; D006360:Heat-Shock Proteins; C080866:cagA protein, Helicobacter pylori